Recombinant Human MMP1 Protein，His

MMP1, or Matrix Metalloproteinase-1, is a crucial enzyme involved in the degradation of the extracellular matrix, playing a significant role in tissue remodeling and repair processes. Its study has garnered attention due to its implications in various physiological and pathological conditions, including wound healing, inflammation, and cancer metastasis. MMP1 is responsible for the cleavage of collagen, particularly type I collagen, which is a fundamental component of the extracellular matrix in connective tissues. Dysregulation of MMP1 activity has been linked to the progression of several diseases, including rheumatoid arthritis and various forms of cancer where it facilitates tumor invasion and metastasis. Researchers have been focused on developing recombinant MMP1 protein for various applications, including the investigation of its biochemical properties, functional roles in cellular processes, and potential therapeutic interventions. The recombinant protein allows for detailed studies on enzyme kinetics, inhibitor design, and the development of specific MMP1 antagonists. Understanding the structure-function relationship of MMP1 can enable the identification of novel therapeutic targets and strategies for diseases characterized by aberrant matrix remodeling. Additionally, MMP1 serves as a model for studying the broader family of matrix metalloproteinases, contributing to the understanding of their diverse roles in health and disease. This research area holds promise for developing innovative treatments that can manipulate MMP1 activity to improve tissue repair, combat cancer spread, and manage other disorders associated with extracellular matrix dysregulation.